The contribution of the endothelium to the development of coagulation disorders that characterize Ebola hemorrhagic fever in primates
- PMID: 16113813
- DOI: 10.1160/TH05-03-0153
The contribution of the endothelium to the development of coagulation disorders that characterize Ebola hemorrhagic fever in primates
Abstract
Recently, there have been substantial developments in the understanding of Ebola hemorrhagic fever pathogenesis, but there are still major gaps. These infections occur in underdeveloped areas of the world, and much of our knowledge of naturally occurring disease is derived from sporadic outbreaks that occurred decades in the past. Recently conducted laboratory animal studies have provided insight into Ebola pathogenesis and may help guide clinical investigations of disease using contemporary methodologies that were not available previously. A better understanding of the relevant host and viral factors that influence clinical and virologic outcome will be critical to our ability to combat this aggressive pathogen. This article reviews the most relevant information relating to the postulated pathogenesis of this disease, focusing on the role of the endothelium in contributing to the coagulation disorders that characterize Ebola hemorrhagic fever in primates. Some of the remaining and key unanswered questions relating to the role of the vascular system in the pathogenesis of this disease, that need to be addressed in further research, are highlighted.
Similar articles
-
Ebola virus: unravelling pathogenesis to combat a deadly disease.Trends Mol Med. 2006 May;12(5):206-15. doi: 10.1016/j.molmed.2006.03.006. Epub 2006 Apr 17. Trends Mol Med. 2006. PMID: 16616875 Review.
-
Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells.Am J Pathol. 2003 Dec;163(6):2371-82. doi: 10.1016/S0002-9440(10)63592-4. Am J Pathol. 2003. PMID: 14633609 Free PMC article.
-
Two strings to the bow of Ebola virus.Nat Med. 1998 Apr;4(4):388-9. doi: 10.1038/nm0498-388. Nat Med. 1998. PMID: 9546777 No abstract available.
-
Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses.J Pathol. 2015 Jan;235(2):153-74. doi: 10.1002/path.4456. J Pathol. 2015. PMID: 25297522 Review.
-
Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever.Int J Biochem Cell Biol. 2005 Aug;37(8):1560-6. doi: 10.1016/j.biocel.2005.02.018. Epub 2005 Mar 7. Int J Biochem Cell Biol. 2005. PMID: 15896665
Cited by
-
Advancements in Marburg (MARV) Virus Vaccine Research With Its Recent Reemergence in Equatorial Guinea and Tanzania: A Scoping Review.Cureus. 2023 Jul 17;15(7):e42014. doi: 10.7759/cureus.42014. eCollection 2023 Jul. Cureus. 2023. PMID: 37593293 Free PMC article.
-
Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product.Sci Rep. 2017 Jun 22;7(1):4099. doi: 10.1038/s41598-017-03910-7. Sci Rep. 2017. PMID: 28642489 Free PMC article.
-
Shed GP of Ebola virus triggers immune activation and increased vascular permeability.PLoS Pathog. 2014 Nov 20;10(11):e1004509. doi: 10.1371/journal.ppat.1004509. eCollection 2014 Nov. PLoS Pathog. 2014. PMID: 25412102 Free PMC article.
-
Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus.J Infect Dis. 2011 Nov;204 Suppl 3(Suppl 3):S991-9. doi: 10.1093/infdis/jir336. J Infect Dis. 2011. PMID: 21987781 Free PMC article.
-
Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus.PLoS Pathog. 2008 Aug 29;4(8):e1000141. doi: 10.1371/journal.ppat.1000141. PLoS Pathog. 2008. PMID: 18769720 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous